Jasper Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $68,861,000.
Profit Margin
| 2019 | 0 | -4.98M | |
|---|---|---|---|
| 2020 | 0 | -31.66M | |
| 2021 | 0 | -23.98M | |
| 2022 | 0 | -24.17M | |
| 2023 | 0 | -64.46M |
JSPRW Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 1.10M | 1.31M | 566K | 21K | 0 |
Gross profit | -1.10M | -1.31M | -566K | -21K | 0 |
Operating exp. | |||||
Research and development | 51.78M | 34.62M | 25.42M | 15.88M | 3.61M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 68.86M | 51.19M | 36.83M | 20.68M | 4.45M |
Operating income | -68.86M | -51.19M | -36.83M | -20.68M | -4.71M |
Other income (expenses), net | 2.76M | 13.51M | 6.19M | -10.98M | -277K |
Income before tax | -66.09M | -37.68M | -30.63M | -31.66M | -4.98M |
Income tax expense | -1.62M | -13.51M | -6.65M | -38.45K | -277 |
Net income | -64.46M | -24.17M | -23.98M | -31.66M | -4.98M |
Earnings per share | |||||
Basic EPS | -6.18 | -6.63 | -21.05 | -114.3 | 0 |
Diluted EPS | -6.18 | -6.63 | -21.05 | -114.3 | 0 |
| Data source | Data source | Data source | Data source | Data source |